Back to BlackRock Finance, Inc. BlackRock Finance, Inc.

NRIXNRIX
3 quarters

Position history for BlackRock Finance, Inc.BlackRock Finance, Inc.'s holdings in NURIX THERAPEUTICS INC

As of its last 13F, for Q2 2024, BlackRock Finance held 6,820,015 shares of NRIX (Nurix Therapeutics), worth $142.3M. It increased the position by 2,239,601 shares (+48.9%) from Q1 2024. BlackRock Finance held NRIX from Q4 2023 to Q2 2024, across 3 quarterly 13F filings.

Current Value

$142.3M

Current Shares

6.8M

Total Value Change

+$94.4M

Total Shares Change

+2.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q2
Latest
Increased
6.8M
+48.9%
$142.3M0.0%$20.87
42
2024-Q1
Decreased
4.6M
-1.4%
$67.3M0.0%$14.70
0
2023-Q4
First report
4.6M
-
$47.9M0.0%$10.32
0

Other major holders of NRIX: BlackRock, Inc., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used